📣 VC round data is live. Check it out!
- Public Comps
- IKS Health
IKS Health Valuation Multiples
Discover IKS Health's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Dallah Healthcare, LifeStance Health, Krishna Institute, Option Care Health and more.
IKS Health Overview
About IKS Health
Inventurus Knowledge Solutions Ltd is a technology enabled healthcare solutions provider, serving the U.S healthcare market. The group offer a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings. It is operates in in Care Enablement, empowering healthcare organizations to deliver high-quality care efficiently and sustainably through an integrated platform that combines technology and deep human expertise. The Company operates in one reportable segment which is Healthcare. Its solutions are Revenue Cycle Management, Clinical Support, and Value-Based Care.
Founded
2006
HQ

Employees
7.5K
Website
Sectors
Financials (LTM)
EV
$3B
Valuation Multiples
Start free trialIKS Health Financials
IKS Health reported last 12-month revenue of $357M and EBITDA of $117M.
In the same LTM period, IKS Health generated $169M in gross profit, $117M in EBITDA, and $78M in net income.
Revenue (LTM)
IKS Health P&L
In the most recent fiscal year, IKS Health reported revenue of $336M and EBITDA of $116M.
IKS Health is profitable as of last fiscal year, with gross margin of 49%, EBITDA margin of 34%, and net margin of 23%.
Financial data powered by Morningstar, Inc.
IKS Health Stock Performance
IKS Health has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
IKS Health's stock price is $17.25.
IKS Health share price decreased by 2.2% in the last 30 days, and by 1.0% in the last year.
IKS Health has an EPS (earnings per share) of $0.45.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | -2.2% | -2.2% | 21.3% | -1.0% | $0.45 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIKS Health Valuation Multiples
IKS Health trades at 8.1x EV/Revenue multiple, and 24.8x EV/EBITDA.
EV / Revenue (LTM)
IKS Health Financial Valuation Multiples
As of June 2, 2026, IKS Health has market cap of $3B and EV of $3B.
IKS Health has a P/E ratio of 36.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified IKS Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


IKS Health Margins & Growth Rates
IKS Health grew revenue by 38% and EBITDA by 27% in the last fiscal year.
In the most recent fiscal year, IKS Health reported gross margin of 49%, EBITDA margin of 34%, and net margin of 23%.
IKS Health Margins
IKS Health Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
IKS Health Operational KPIs
IKS Health's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
IKS Health's Rule of 40 is 66% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
IKS Health's Rule of X is 117% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
IKS Health Competitors
IKS Health competitors include Dallah Healthcare, LifeStance Health, Krishna Institute, Option Care Health, Concentra Group, Meinian Onehealth, Guardian Pharmacy Service, Topchoice Medical, Global Health and Medicover.
Most IKS Health public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.5x | 3.4x | 19.3x | 16.9x | |||
| 2.3x | 2.2x | 20.9x | 18.3x | |||
| 8.8x | 8.4x | 41.8x | 40.5x | |||
| 0.8x | 0.8x | 9.1x | 9.1x | |||
| 2.4x | 2.4x | 12.3x | 11.8x | |||
| 2.5x | 2.4x | 11.8x | 13.2x | |||
| 1.7x | 1.7x | 21.3x | 20.6x | |||
| 5.9x | 5.6x | 18.3x | 17.8x | |||
This data is available for Pro users. Sign up to see all IKS Health competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by IKS Health
IKS Health has acquired 4 companies to date.
Last acquisition by IKS Health was on May 12th 2026. IKS Health acquired ARAI Solutions for undisclosed valuation.
Latest Acquisitions by IKS Health
| Description | ARAI Solutions is an AI company developing services and products from applied research for production-grade healthcare applications. | TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are Revenue Cycle Management (RCM), (ii) Electronic Health Records (EHR), and (iii) Patient Engagement The company derives maximum revenue from the RCM segment. | ThinkDTM is an AI-native firm offering product strategy consulting, digital services like websites, small-business CTO support, and OKR-style organizational goal setting. | AQuity Solutions is a healthcare technology firm specializing in clinical documentation improvement, medical coding, and revenue integrity services. Boston-headquartered, the company combines IT automation with human expertise to maximize return on investment for hospitals and health systems. Its platforms streamline coding accuracy, reduce denials, and ensure compliance with regulations like ICD-10 and HCC methodologies across the United States. |
| HQ Country | ||||
| HQ City | Bangalore | - | New York, NY | Raleigh, NC |
| Deal Date | 12 May 2026 | 22 Apr 2026 | 30 Mar 2026 | 31 Oct 2023 |
| Valuation | undisclosed | $565M | undisclosed | $200M |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all IKS Health acquisitions and their M&A valuation multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout IKS Health
| When was IKS Health founded? | IKS Health was founded in 2006. |
| Where is IKS Health headquartered? | IKS Health is headquartered in India. |
| How many employees does IKS Health have? | As of today, IKS Health has over 7K employees. |
| Is IKS Health publicly listed? | Yes, IKS Health is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of IKS Health? | IKS Health trades under IKS ticker. |
| When did IKS Health go public? | IKS Health went public in 2024. |
| Who are competitors of IKS Health? | IKS Health main competitors include Dallah Healthcare, LifeStance Health, Krishna Institute, Option Care Health, Concentra Group, Meinian Onehealth, Guardian Pharmacy Service, Topchoice Medical, Global Health, Medicover. |
| What is the current market cap of IKS Health? | IKS Health's current market cap is $3B. |
| What is the current revenue of IKS Health? | IKS Health's last 12 months revenue is $357M. |
| What is the current revenue growth of IKS Health? | IKS Health revenue growth (NTM/LTM) is 36%. |
| What is the current EV/Revenue multiple of IKS Health? | Current revenue multiple of IKS Health is 8.1x. |
| What is the current EBITDA of IKS Health? | IKS Health's last 12 months EBITDA is $117M. |
| What is IKS Health's EBITDA margin? | IKS Health's last 12 months EBITDA margin is 33%. |
| What is the current EV/EBITDA multiple of IKS Health? | Current EBITDA multiple of IKS Health is 24.8x. |
| What is the current FCF of IKS Health? | IKS Health's last 12 months FCF is $64M. |
| What is IKS Health's FCF margin? | IKS Health's last 12 months FCF margin is 18%. |
| What is the current EV/FCF multiple of IKS Health? | Current FCF multiple of IKS Health is 45.2x. |
| How many companies IKS Health has acquired to date? | As of June 2026, IKS Health has acquired 4 companies. |
| What was the largest acquisition by IKS Health? | $565M acquisition of TruBridge on 22nd April 2026 was the largest M&A IKS Health has done to date. |
| What companies IKS Health acquired? | IKS Health acquired TruBridge, AQuity Solutions, ThinkDTM, and ARAI Solutions. |
| In how many companies IKS Health has invested to date? | IKS Health hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to IKS Health
Lists including IKS Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

